URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new drug cocktail in fight against tough cancers
Disease control OngoingThis early-stage study aims to find the highest safe dose of three cancer drugs—gemcitabine, doxorubicin, and bortezomib—when given together. It is for people with advanced solid tumors or urethral cancer that cannot be removed by surgery and have not responded to standard treatm…
Matched conditions: URETHRAL CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Four-Pronged attack on rare, aggressive bladder cancers
Disease control OngoingThis study tested a combination of four chemotherapy drugs (5-FU, leucovorin, gemcitabine, and cisplatin) in patients with advanced adenocarcinomas of the bladder, urethra, or a related structure called the urachal remnant. The main goals were to see how well the drug combo could…
Matched conditions: URETHRAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC